Creo Medical Group Debt 2024

Creo Medical Group Aktienanalyse

What does Creo Medical Group do?

Creo Medical Group PLC is a British medical technology company that was founded in 2003 and is based in Chepstow, Wales. The company specializes in the development and marketing of innovative medical devices. Creo Medical aims to improve the lives of healthcare professionals and patients by providing them with state-of-the-art technology. The company's business model focuses on research, development, and sales of innovative medical devices. Their goal is to provide doctors with the most advanced technology to facilitate their work. Creo Medical offers a wide range of devices for endoscopic surgery. They follow an asset-light model, outsourcing production to save costs and increase efficiency. Creo Medical was founded in 2003 by a team of professionals consisting of doctors and engineers. Their objective was to promote the development of cutting-edge technology for the medical industry and improve the treatment of patients worldwide. The company quickly gained momentum and received its first patent in 2014. Their product range includes endoscopes and electrosurgical devices for endoscopic surgery. Endoscopes are used to visualize the internal surfaces of the body through a flexible tube inserted through a small incision. This type of technology is used in surgery, particularly in gastrointestinal and gynecological areas. Electrosurgical devices are used in heart surgery and to prevent bleeding during operations. Creo Medical operates in various sectors where their products are utilized: 1. Gastroenterology: focusing on the diagnosis and treatment of digestive tract diseases. 2. Laparoscopic surgery: a surgical technique that uses a few small incisions to introduce surgical instruments into the body. 3. Gynecology: dealing with the diagnosis and treatment of diseases in the female reproductive system. 4. Urology: involving the treatment of diseases in the urinary tract and male reproductive system. Creo Medical serves multiple markets and recently announced the acquisition of Albyn Medical, a leading British manufacturer and distributor of medical devices. The company reported a 68% increase in revenue to £8.8 million in 2020, attributing the growth to growing demand for laparoscopic and gastroenterological products. Creo Medical's stock was listed on London's AIM in 2018. In conclusion, Creo Medical is a British medical technology company specializing in the development, manufacturing, and marketing of medical devices used in various medical fields. Their advanced technologies contribute to breakthroughs in surgery, making procedures more precise and gentle. Creo Medical has become a significant player in the British and international medical industry and will continue to play an important role in this sector. Creo Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Creo Medical Group's Debt Structure

Creo Medical Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Creo Medical Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Creo Medical Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Creo Medical Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Creo Medical Group stock

What is the debt of Creo Medical Group this year?

Creo Medical Group has a debt level of 5.3 GBP this year.

What was the debt of Creo Medical Group compared to the previous year?

The debt of Creo Medical Group has increased by -474.82% compared to the previous year dropped.

What are the consequences of high debt for investors in Creo Medical Group?

High debt can pose a risk for investors of Creo Medical Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Creo Medical Group?

Low debt means that Creo Medical Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Creo Medical Group affect the company?

An increase in debt of Creo Medical Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Creo Medical Group affect the company?

A reduction in debt of Creo Medical Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Creo Medical Group?

Some factors that can influence the debt of Creo Medical Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Creo Medical Group so important for investors?

The debts of Creo Medical Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Creo Medical Group take to change the debt?

To change the debt, Creo Medical Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Creo Medical Group pay?

Over the past 12 months, Creo Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Creo Medical Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Creo Medical Group?

The current dividend yield of Creo Medical Group is .

When does Creo Medical Group pay dividends?

Creo Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Creo Medical Group?

Creo Medical Group paid dividends every year for the past 0 years.

What is the dividend of Creo Medical Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Creo Medical Group located?

Creo Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Creo Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Creo Medical Group from 7/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Creo Medical Group pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Creo Medical Group in the year 2023?

In the year 2023, Creo Medical Group distributed 0 GBP as dividends.

In which currency does Creo Medical Group pay out the dividend?

The dividends of Creo Medical Group are distributed in GBP.